Assessing the ‘added value’ of European policy on new psychoactive substances
Saved in:
Chatwin, C., Assessing the ‘added value’ of European policy on new psychoactive substances. International Journal of Drug Policy, vol. 40, 2017, p. 111-116.
Ref.
521913
Location:
SIIS Archivo (R.1114)
Palabras clave:
Drogodependencias, Drogas legales, Drogas ilegales, Innovaciones, Acción contra las drogodependencias, Reducción de daños, Normativa, Europa
Drogodependencias, Drogas legales, Drogas ilegales, Innovaciones, Acción contra las drogodependencias, Reducción de daños, Normativa, Europa
Similar Items: Assessing the ‘added value’ of European policy on new psychoactive substances
- Can new psychoactive substances be regulated effectively? An assessment of the British Psychoactive Substances Bill
- New psychoactive substances: Current health-related practices and challenges in responding to use and harms in Europe
- New psychoactive substances and human enhancement drugs
- New psychoactive substances: Are there any good options for regulating new psychoactive substances?
- Drug policy and global regulatory capitalism: The case of new psychoactive substances (NPS)
- Online test purchased new psychoactive substances in 5 different European countries: A snapshot study of chemical composition and price